Maryam Saleh, a Cyberkinetics Inc. clinical research assistant, holds a brain gate censor, which will be implanted beneath the skull, at the company in Foxboro, Mass., Tuesday, April 13, 2004. Cyberkinetics of Foxboro has received Food and Drug Administration approval to begin a clinical trial in which four-square-millimeter chips will be implanted beneath the skulls of paralyzed patients. If successful, the chips could allow patients to send computer commands, essentially by thinking about them. (AP Photo/Chitose Suzuki)


Image Info

Leave a Reply

Your email address will not be published. Required fields are marked *